✦ LIBER ✦

594 A Phase I Dose-escalation, Pharmacokinetic (PK) and Pharmacodynamic (PD) Evaluation of LY2940680, an Oral Smo Inhibitor

✍ Scribed by Bendell, J.; Weiss, G.; Infante, J.; Ramanathan, R.; Jones, S.; Korn, R.; Burris, H.; Brail, L.; Jones, E.; Von Hoff, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

135 A clinical phase I dose escalation,

✍ K. Mross; F. Baas; M. Medinger; J. Drevs; R. Strecker; J. Hennig; M. Wolters; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

399 POSTER A Phase 1 dose-escalation, ph

✍ G.R. Simon; M. Fishman; A.M. Dellaportas; D. Sullivan; L.H. Brail; V. Andre; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

706 POSTER A phase I dose escalation pha

✍ S. Chia; K. Chi; C. Kollmannsberger; K. Paton; K. Bhagat; S. D'Aloisio; A. Das-G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

386 POSTER Pharmacokinetic (PK) and phar

✍ T.A. Yap; J. Barriuso; S. Frentzas; R. Riisnaes; J. Clark; J. Dukes; A. Futreal; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

1204 A Phase I study evaluating the phar

✍ R. Kristeleit; D. Sarker; M. Forster; M. Lolkema; D. Olmos; K. Mazina; M.V. Dole 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Phase I, open-label, multicentre, dose-e

✍ Patrick Schöffski; Suzanne F. Jones; Herlinde Dumez; Jeffrey R. Infante; Elke Va 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 215 KB